Press
Press Releases
SCA´s acquisition of BSN medical now closed
Luxembourg, April 03, 2017
SCA’s acquisition of BSN medical, a leading medical solutions company, has been closed.
The purchase price for the shares amounts to EUR 1,400m and takeover of net debt to approximately EUR 1,340m1). SCA consolidates BSN medical as of April 3, 2017.
SCA is a leading global hygiene and forest products company that sustainably develops, produces, markets and sells personal care, tissue and forest products. Sales are conducted in about 100 countries under many strong brands, including the leading global brands TENA and Tork, and regional brands, such as Libero, Libresse, Lotus, Nosotras, Saba, Tempo, Vinda and Zewa.
As Europe’s largest private forest owner, SCA places considerable emphasis on sustainable forest management. The Group has about 46,000 employees. Sales in 2016 amounted to approximately SEK 117bn (EUR 12.4bn). SCA was founded in 1929, has its headquarters in Stockholm, Sweden, and is listed on NASDAQ Stockholm. More information at www.sca.com.
BSN medical acquires JoViPak® to become a full solution provider in lymphology
Hamburg, Germany September 7, 2015
- STRENGTHENING BSN’S MARKET-LEADING POSITION FOR LYMPHOEDEMA MANAGEMENT
- GAINING STRONG FOOTHOLD IN ATTRACTIVE AND RAPIDLY DEVELOPING SEGMENT
BSN medical continues to strengthen its position as a market-leading provider of lymphoedema therapy solutions with the purchase of JoViPak®, a manufacturer of lymphoedema garments. This acquisition complements BSN’s comprehensive product portfolio designed for the management of lymphatic disorders and allows the company to cater to the underserved yet rapidly growing market of lymphoedema management during the day and nighttime.
BSN’s acquisition of JoViPak is an attractive complement to the recently announced acquisition of FarrowMed, which provides BSN with the patented FarrowWrap® compression wrap used to manage lymphoedema.
...
BSN medical acquires JoViPak® to become a full solution provider in lymphology
Hamburg, Germany September 7, 2015
- Strengthening BSN’s market-leading position for lymphoedema management
- Gaining strong foothold in attractive and rapidly developing segment
BSN medical continues to strengthen its position as a market-leading provider of lymphoedema therapy solutions with the purchase of JoViPak®, a manufacturer of lymphoedema garments. This acquisition complements BSN’s comprehensive product portfolio designed for the management of lymphatic disorders and allows the company to cater to the underserved yet rapidly growing market of lymphoedema management during the day and nighttime. BSN’s acquisition of JoViPak is an attractive complement to the recently announced acquisition of FarrowMed, which provides BSN with the patented FarrowWrap® compression wrap used to manage lymphoedema.
...
BSN medical acquires FarrowMed to further expand its lymphoedema therapy solutions
Hamburg, Germany June 29, 2015
- Strengthening BSN’s market-leading position for lymphoedema and venous disease management
- Innovative product portfolio improves access to growing market
BSN medical continues to strengthen its position as a market leading provider of lymphoedema therapy solutions by acquiring FarrowMed and its range of patented FarrowWrap® and related compression garment technologies, which focus on the management of lymphoedema and venous disease. The acquisition further enhances BSN medical’s comprehensive product portfolio for the management of lymphatic and venous disorders under the JOBST® and Elvarex® brands.
...
BSN medical and Terumo strengthen their market position in Japan
Hamburg/Tokyo, 31 March 2015
- Joint venture will provide significant growth potential for BSN’s Wound Care & Vascular franchise
- Important step towards increased sales in highly attractive market
Today BSN medical and Terumo Corporation have announced a revised joint venture agreement that will further strengthen their joint position in the Japanese market. The Joint Venture will tap into the significant growth potential for BSN medical's Advanced Wound Care business, and will provide Terumo with long-term access to BSN medical's impressive product range. The joint venture will see a significant rise in revenue as the result of increased sales force activities alongside a new dedicated JV sales promotion team. These will leverage the strength of Terumo's existing sales force of 200 in the Japanese market.
...
BSN medical acquires Sorbion to strengthen its position in Wound Care
Hamburg, 27 November 2014
- Enhancing BSN’s Wound Care & Vascular franchise with leading superabsorbent wound dressings
- Acquisition of innovative technology and patents for the treatment of chronic wounds today and in the future
BSN medical has taken another significant step to strengthen its portfolio in the highly attractive Wound Care market by acquiring Sorbion, a specialised technology company, focussing on products for the treatment of chronic wounds. This acquisition complements BSN’s recent launch of the Negative Pressure Wound Therapy (NPWT) system, Cura Sul®. Both steps broaden BSN’s complete offering to patients suffering from acute and chronic wounds, and further improve its position among the leading companies in Wound Care.
...
Tel: 1300 BSN MED (1300 276 633)
Fax: 1300 998 830
